Plenty of winners could be found this week among health-care stocks. Unfortunately for some shareholders, these three weren't among those winners.

One of the week's big losers felt the sting of a delay by the U.S. Food and Drug Administration. Another reported poor financial results, although those results likely caught few by surprise. The third horrendous performer got slammed by speculation that the company could announce bad news soon.

Which three health-care stocks were utterly crushed by the market this week? Find out by watching the slideshow below.


This article represents the opinion of the writer, who may disagree with the “official” recommendation position of a Motley Fool premium advisory service. We’re motley! Questioning an investing thesis -- even one of our own -- helps us all think critically about investing and make decisions that help us become smarter, happier, and richer.